![Michael Krebs](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profiel
Mr. Michael Krebs is a Head of Customer Service & Member of the Executive Board at Privatbank Von Graffenried AG and a Chief Executive Officer at HeartBeat.bio AG.
Actieve functies van Michael Krebs
Bedrijven | Functie | Begin |
---|---|---|
Privatbank Von Graffenried AG
![]() Privatbank Von Graffenried AG Investment ManagersFinance Part of Von Graffenried Holding AG, Privatbank Von Graffenried AG is a Swiss company that provides investment advice. The company is based in Bern, Switzerland. The company was founded in 1979. Marcel Eggimann has been the CEO of the company since 1996. | Portefeuillebeheerder-Aandelen | 01-01-2008 |
Heartbeat.bio AG
![]() Heartbeat.bio AG Miscellaneous Commercial ServicesCommercial Services HeartBeat.bio AG is an Austrian company that specializes in developing a high-throughput human organoid screening platform for cardiac drug discovery. HeartBeat.bio is based in Vienna, AT, at the Biocenter. The company's technology platform is based on self-organizing, scalable cardiac organoids that replicate human heart physiology, allowing for modeling of various diseases such as drug-induced and genetic cardiomyopathies, myocardial infarction, heart remodeling, and regeneration. The company was founded in 2021 by a team with extensive experience in organoid research, drug discovery, and business development. Michael Krebs has been the CEO since incorporation. | Algemeen Directeur | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Privatbank Von Graffenried AG
![]() Privatbank Von Graffenried AG Investment ManagersFinance Part of Von Graffenried Holding AG, Privatbank Von Graffenried AG is a Swiss company that provides investment advice. The company is based in Bern, Switzerland. The company was founded in 1979. Marcel Eggimann has been the CEO of the company since 1996. | Finance |
Heartbeat.bio AG
![]() Heartbeat.bio AG Miscellaneous Commercial ServicesCommercial Services HeartBeat.bio AG is an Austrian company that specializes in developing a high-throughput human organoid screening platform for cardiac drug discovery. HeartBeat.bio is based in Vienna, AT, at the Biocenter. The company's technology platform is based on self-organizing, scalable cardiac organoids that replicate human heart physiology, allowing for modeling of various diseases such as drug-induced and genetic cardiomyopathies, myocardial infarction, heart remodeling, and regeneration. The company was founded in 2021 by a team with extensive experience in organoid research, drug discovery, and business development. Michael Krebs has been the CEO since incorporation. | Commercial Services |